Evox Therapeutics
Transformative Exosome Therapeutics
Oxford, United Kingdom · Founded 2016 · $153.8M raised
- Headquarters
- Oxford
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- evoxtherapeutics.com
- Total Funding
- $153.8M
- Last Round
- $95.4M Series CFeb 2021
- Rounds
- 3
About
Evox Therapeutics develops exosome-based genome editing therapies targeting rare neurological and neurodegenerative diseases.
Summary
Evox Therapeutics is a Biotech company based in Oxford, United Kingdom, founded in 2016. It has raised $153.8M in total across 3 rounds, most recently a $95.4M Series C round in Feb 2021. Investors include Redmile Group, Oxford Science Enterprises and GV.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...